HRS-7525
/ Jiangsu Hengrui Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
August 04, 2026
A Clinical Study of HRS-7525 Tablets in Patients With Advanced Prostate Cancer
(clinicaltrials.gov)
- P1 | N=320 | Recruiting | Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Genito-urinary Cancer • Oncology • Prostate Adenocarcinoma • Prostate Cancer • Solid Tumor
July 18, 2026
A Clinical Study of HRS-7525 Tablets in Patients With Advanced Prostate Cancer
(clinicaltrials.gov)
- P1 | N=320 | Not yet recruiting | Sponsor: Jiangsu HengRui Medicine Co., Ltd.
New P1 trial • Genito-urinary Cancer • Oncology • Prostate Adenocarcinoma • Prostate Cancer • Solid Tumor
1 to 2
Of
2
Go to page
1